Navigation Links
Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
Date:5/15/2008

opriate management, atrial fibrillation can lead to serious complications, such as stroke and congestive heart failure.

AF is a condition in which the upper chambers of the heart beat in an uncoordinated and disorganized fashion, resulting in an irregular and fast heart rhythm (i.e. an irregular heartbeat). Atrial flutter is an abnormal fast heart rhythm that occurs in the atria of the heart. This rhythm occurs often in individuals with other heart conditions (e.g. pericarditis, coronary artery disease, and cardiomyopathy). Atrial flutter frequently degenerates to atrial fibrillation. However, it may persist for months to years.

When blood is not completely pumped out of the heart's chambers, it can pool and clot. If a blood clot forms in the atria, it can exit the heart and block an artery in the brain, resulting in a stroke. Consequently, about 15 percent of all strokes result from atrial fibrillation.

The most common symptoms of atrial fibrillation include palpitations (a rapid, irregular, "flopping" movement or pounding sensation in the chest or neck), shortness of breath, dizziness and feeling of heaviness, or constriction in the chest. The disorder may even be more common than diagnosed, as patients may experience atrial fibrillation episodes that either do not cause symptoms or are not documented during their visits to the doctor.

About the ATHENA Study

The landmark ATHENA study is a randomized, placebo controlled, international metacentre study that evaluated for the first time a treatment on top of standard background therapy for the management of patients with atrial fibrillation in reducing morbidity and mortality by preventing cardiovascular hospitalizations or death from any cause. The study included 4,628 patients, which made it the largest ever outcome study of an anti- arrhythmic treatment for atrial fibrillation.

The ATHENA study objectives were to show a potential benefit of Multaq(R) on primary composite e
'/>"/>

SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

9

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial
2. Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population
3. JACC Identifies DEFER with 5-year Outcomes as Landmark Trial
4. Hospital Launches Landmark Emergency Medicine Project
5. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
6. Viatronix V3D-Colon Utilized in Another Landmark Study
7. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
8. Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization
9. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
10. Ceremeds OSTENE(R) Improves Bone Fusion and Healing After Surgery, New Study Shows
11. St. Jude Study Shows How T Cells Machinery Dials Down Autoimmunity

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... /PRNewswire/ -- On Sept. 11, 2001, thousands of...rkers came together to save as many lives as possi...Cauley was one of those 9/11 first responders. Now...n his late 30s, McCauley was diagnosed with cancer...hemotherapy treatments, leaving him confined to a ...
(Date:11/9/2009)...e/ -- AMD LASERS just announced that industry lead...pted the position of Medical Director. In his new...g research and development of new soft and hard ti...ontinuing education credits, authoring articles fo... lecturing and seminar engagements. ,, "We are ...
(Date:11/9/2009)...Newswire/ -- LifeNet Health, a leading allograft b...raft Cervical Bio-Implant (VG2C) with Preservon...prietary glycerol-based preservation solution that...ully hydrated state at ambient temperature. This e...lants, doing away with lengthy thawing and rehydra...
Breaking Medicine Technology:The SCOOTER Store Surprises 9/11 First Responder & Merrick Firefighter With Power Chair 2The SCOOTER Store Surprises 9/11 First Responder & Merrick Firefighter With Power Chair 3AMD LASERS Names Dr. James Jesse as Medical Director 2LifeNet Health Announces First Bio-Implant with New Preservation Technology 2SXC Health Solutions to present at upcoming conferences 58075 1SXC Health Solutions to present at upcoming conferences 58075 2Study Suggests a Wider Use for Statins 58073 1Study Suggests a Wider Use for Statins 58073 2Study Suggests a Wider Use for Statins 58073 3Georgia State researcher to use 241 million grant to improve computer models for fighting wildfires 10045 1Georgia State researcher to use 241 million grant to improve computer models for fighting wildfires 10045 2
...mab Cancer Trial Is Evaluating the, Anti-Tumor A...atin and Paclitaxel --...als, Inc. (Nasdaq: PPHM ) today announced that pa... trial designed to evaluate the safety,and efficac...in patients,with non-small cell lung cancer (NSCLC...
...etics,(Nasdaq: DCGN ) today announced positive to...y study of DG041, the company,s first-in-class,ant...developed as a,next-generation oral anti-platelet ... increasing bleeding risk. The prospective, random... on platelet activation and,bleeding time of DG041...
Other Medicine Technology:Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 2Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 3Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 4DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix(TM) or Aspirin 2DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix(TM) or Aspirin 3DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix(TM) or Aspirin 4
(Date:11/9/2009)... Tarkett Sports, the worldwide leader in s...r product offering with a more complete and innova...of indoor sports flooring experts and the launch o... (PRWEB) November 9, 2009 -- Tarkett Spor...s flooring products includes hardwood and syntheti...
(Date:11/9/2009)...r Awareness Month Highlighted During Broadcast ,...Lung Cancer Alliance (LCA) announced that LCA staf...l for the New York Stock Exchange(TM) (NYSE) tomor...www.newscom.com/cgi-bin/prnh/20081016/LCALOGO ) ,... LCA-NY advocate, Richard Heimler will mark the en...
(Date:11/9/2009)... Calif., Nov. 9 Sutter Health, a f...er health care service providers, is donating $255...ariety of local food banks will share the quarter-...als on the tables of thousands of families across ...history of partnering with and supporting charitab...
(Date:11/9/2009)...on backs President Obama,s promise to not expand a...,, Bishops still concerned for poor, elderly ...- Cardinal Francis George of Chicago, president of... lauded the November 7 decision of the U.S. House ...form money from paying for elective abortions. ,...
(Date:11/9/2009)...t atrial enlargement, study finds , , MO...r risk factor for left atrial enlargement, which i...nd death, a new study shows. , Atrial fibrillat...gular heart rhythm or heartbeat). , Researcher... 74, in Germany who were followed for 10 years. Th...
Breaking Medicine News(10 mins):Health News:Tarkett Sports Launches Revamped Indoor Sports Flooring Division and New Indoor Website 2Health News:Lung Cancer Alliance Staff and Advocates to Ring Closing Bell of New York Stock Exchange(TM) 2Health News:Sutter Health Donates $255,000 to Help the Hungry This Holiday Season 2Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 2Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 3
...UT Southwestern Medical Center are the first in Te...ctive pellet, or seed, is implanted into a mass or...xact location for surgical removal. , During the ... a wand that detects radioactivity to locate the m...
...ent to Hologic,s 1999 Equity ...ologic, Inc.,(Nasdaq: HOLX ), a leading provider ... systems directed towards women,s health, today an...ytyc,Corporation (Nasdaq: CYTC ). In addition, I...
...nd Provides Sample Appeal,Letter, WASHINGTON, Oct...n many seniors peace of mind that they will have,a..., because of individual,plan rules, the medicine t...t., To equip seniors with the knowledge they need...
...l Health Care,will formally announce a $2 million ...its recent total of health care education donation...ntributed $1 million to Union University,s,nursing...g to ensure the future of health care in our commu...
...efficiency, improves dispensing, accuracy, and al...s and inventory, MO...aq: OMCL ) a leading provider of system solutions...automation solution.,With its new user-friendly gr...
...tion Testifies on the Hill, WASHINGTON, Oct. 11 ...o play in the protection of at-risk,children and t... according,to testimony by the head of the industr...an work together to,safeguard and help those who n...
Other Medicine News:Health News:New 'seed' therapy helps pinpoint breast tumors with more accuracy 2Health News:ISS Recommends Hologic Stockholders Vote 'FOR' Merger With Cytyc 2Health News:ISS Recommends Hologic Stockholders Vote 'FOR' Merger With Cytyc 3Health News:ISS Recommends Hologic Stockholders Vote 'FOR' Merger With Cytyc 4Health News:New Resource Explains What Seniors Can Do if Medicare Denies Coverage of Their Medicines 2Health News:Baptist Memorial Health Care Donates More Than $3 Million to Tennessee Universities and Colleges 2Health News:Omnicell Introduces the Next Generation Central Pharmacy Automation Solution 2Health News:Omnicell Introduces the Next Generation Central Pharmacy Automation Solution 3Health News:State Licensure and Oversight Necessary 2
Max-Rom Acetabular Liners
Bio-Modular Total Shoulder System
Cofield 2 Total Shoulder System
Olympia Total Shoulder System
Medicine Products: